FANCB and acute myeloid leukemia: A statistically significant correlation was found between FAMLF-1 and miR-181a expression levels in patients with AML (R = 0.3050; P = 0.0151), FAB non-M2 (R = 0.3542; P = 0.0231), FAB-M5(R = 0.05738; P = 0.0027), but not in patients with FAB-M2(R = 0.1700; P = 0.4495).